Načítá se...
Endogenous expression mapping of malignant melanoma by mass spectrometry imaging
BACKGROUND: Currently, only a limited number of molecular biomarkers for malignant melanoma exist. This is the case for both diagnosing the disease, staging, and efficiently measuring the response to therapy by tracing the progression of disease development and drug impact. There is a great need to...
Uloženo v:
| Vydáno v: | Clin Transl Med |
|---|---|
| Hlavní autoři: | , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Berlin Heidelberg
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6077138/ https://ncbi.nlm.nih.gov/pubmed/30079437 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40169-018-0201-x |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|